Pain Physician COVID-19 Special Issue Now Online
Pain Physician, the official journal of ASIPP, has launched a special issue covering COVID-19 issues. The publications range from understanding the pathophysiological mechanisms, epidemiology, implications on interventional pain practices, safety and effectiveness of various modalities of drug therapy, telemedicine, along with the effect on interventional pain management practices, and, finally, the technological impact of COVID-19 on the future of education and health care delivery and multiple guidelines.
Pain Physician published COVID-19 special issue with 18 original manuscripts and multiple letters. This issue includes an amazing editorial [ https://pubmed.ncbi.nlm.nih.gov/32942783/ ];
Evidence-Based Risk Mitigation Strategies and Stratification during COVID-19 for Return to Interventional Pain Practices [ https://pubmed.ncbi.nlm.nih.gov/32942784/ ], and Triaging Interventional Pain Procedures during COVID-19 or Related Elective Surgery Restrictions [ https://pubmed.ncbi.nlm.nih.gov/32942785/ ].
Both manuscripts describe various means to continuation of the services at present, and also in future if there is a resurgence or in a worst-case scenario lock-down, and training and education during COVID epidemic. Other articles include Burnout among Pain Physicians, Implications on Interventional Pain Practice, and manuscripts on antibody testing, drug therapy, and stem cell therapy.
COVID-19 special issue of Pain Physician this week discusses steroid distancing with evidence-based with or without influence of COVID-19, by Manchikanti et al [ https://pubmed.ncbi.nlm.nih.gov/32942792/ ]. This is proceeded by another manuscript, Lack of Superiority of Epidural Injections with Lidocaine with Steroids Compared to Without Steroids in Spinal Pain by Knezevic et al [ https://pubmed.ncbi.nlm.nih.gov/32942786/ ] which in detail provides the evidence-based data with systematic reviews.
In other manuscripts similar descriptions have been provided (Shanthanna et al https://pubmed.ncbi.nlm.nih.gov/32798067/ and Manchikanti et al [ https://pubmed.ncbi.nlm.nih.gov/32335757/ ]. Overall, it appears that steroids are superior in patients with presence of inflammation and may be indicated in cervical epidural injections to avoid local anesthetic injections.
Shalini Shah, MD, Sudhir Diwan, MD, Amol Soin, MD, Kartic Rajput, MD, PhD, Amit Mahajan, MBBS, Laxmaiah Manchikanti, MD, Alan D. Kaye, MD, PhD, Joshua A. Hirsch, MD, and Christopher Gharibo, MD
Christopher Gharibo, MD, Amit Sharma, MD, Amol Soin, MD, Shalini Shah, MD, Sudhir Diwan, MD, Ricardo Buenaventura, MD, Devi E. Nampiaparampil, MD, Steve M. Aydin, DO, Sanjay Bakshi, MD, Salahadin Abdi, MD, PhD, Sachin “Sunny” Jha, MD, MS, Harold J. Cordner, MD, Alan D. Kaye, MD, PhD, Alaa Abd-Elsayed, MD, Kenneth D. Candido, MD, Nebojsa Nick Knezevic, MD, PhD, Sairam Atluri, MD, Bradley W. Wargo, DO, Mahendra R. Sanapati, MD, Sukdeb Datta, MD, Joshua A. Hirsch, MD, and Laxmaiah Manchikanti, MD
Nebojsa Nick Knezevic, MD, PhD, Laxmaiah Manchikanti, MD, Ivan Urits, MD, Vwaire Orhurhu, MD, MPH, Brahma Prasad Vangala, MBBS, Rachana Vanaparthy, MBBS, Mahendra R. Sanapati, MD, Shalini Shah, MD, Amol Soin, MD, Amit Mahajan, MBBS, Sairam Atluri, MD, Alan D. Kaye, MD, PhD, and Joshua A. Hirsch, MD
Sachin “Sunny” Jha, MD, MS, Shalini Shah, MD, Michael David Calderon, MS, Amol Soin, MD, and Laxmaiah Manchikanti, MD